Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 14;5(23):5112-5115.
doi: 10.1182/bloodadvances.2021005061.

Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCL

Jemima H Miller  1 , Michael Gilbertson  1   2 , Michael P MacManus  3   4 , Andrew Wirth  3   4 , Stephen S Opat  1   2 , Gareth P Gregory  1   2
Affiliations

Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCL

Jemima H Miller et al. Blood Adv. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Event-free survival from radiotherapy commencement for the cohort of 18 patients.
See this image and copyright information in PMC

References

    1. Freeman CL, Savage KJ, Villa DR, et al. . Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP. Blood. 2021;137(7):929-938. - PubMed
    1. Wirth A, Mikhaeel NG. PET response-guided radiotherapy for advanced DLBCL? Blood. 2021;137(7):866-867. - PubMed
    1. Fluge Ø, Mannsåker B, Torp A, et al. . Consolidative radiotherapy to residual masses after chemotherapy is associated with improved outcome in diffuse large B-cell lymphoma. A retrospective, population-based study. Clin Lymphoma Myeloma Leuk. 2018; 18(2):125-135.e3. - PubMed
    1. Moser EC, Kluin-Nelemans HC, Carde P, et al. . Impact of involved field radiotherapy in partial response after doxorubicin-based chemotherapy for advanced aggressive non-Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys. 2006;66(4):1168-1177. - PubMed
    1. Illidge T, Specht L, Yahalom J, et al. ; International Lymphoma Radiation Oncology Group . Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2014;89(1):49-58. - PubMed

Publication types

MeSH terms

LinkOut - more resources